← All projects
Medicines

Gero AI ageing-target discovery

Gero

If the effect in people is large enough, this could become a medicine used to slow one or more processes that drive age-related decline.

WHAT IT IS TRYING TO CHANGE

What the project is doing

Gero AI ageing-target discovery is being developed as part of the wider effort to prevent, delay or repair age-related decline.

What this could do for you

If the effect in people is large enough, this could become a medicine used to slow one or more processes that drive age-related decline.

What has to happen next

The next checkpoint is a defined experiment, development partner or route into human testing.

What could stop it

The idea may never become a practical treatment, even when the biological reasoning is interesting.

WHERE IT STANDS

Current evidence and outlook

Gero AI ageing-target discovery is being developed as part of the wider effort to prevent, delay or repair age-related decline.

Likely path

Usually 10 years or more from broad availability if the idea continues to progress.

Why this estimate

The next meaningful step is stronger laboratory evidence or a defined development programme.

Record checked: 2026-08-27

ORIGINAL EVIDENCE

Research details and sources

The sources below support the project record. RejuvAccess separately checks whether a practical route is open and worth pursuing.

  1. Gero — official programme page
MAKE IT PERSONAL

Could this matter for your situation?

Ask RejuvAccess to check the evidence, access route, cost and next step for you.

Start an access check